<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g401" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-399.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-0.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-394.html" >Sexual Assault and STDs</a><span class="carrot"> > </span>
                    <a href="lv-399.html" >Adults and Adolescents</a><span class="carrot"> > </span>
                    <a href="lv-399.html" >Other Management Considerations</a><span class="carrot"> > </span>Recommendations for Postexposure Assessment of Adolescent and Adult Survivors Within 72 Hours of Sexual Assault
            </div>
            </br><h4 id="sigil_toc_id_401">
 Recommendations for Postexposure Assessment of Adolescent and Adult Survivors Within 72 Hours of Sexual Assault
</h4>
<p>
 &bull; Assess risk for HIV infection in the assailant.
</p>
<p>
 &bull; Evaluate characteristics of the assault event that might increase risk for HIV transmission.
</p>
<p>
 &bull; Consult with a specialist in HIV treatment, if PEP is being considered.
</p>
<p>
 &bull; If the survivor appears to be at risk for HIV transmission&nbsp;from the assault, discuss antiretroviral prophylaxis, including toxicity and lack of proven benefit.
</p>
<p>
 &bull; If the survivor chooses to start antiretroviral PEP (78), provide enough medication to last until the next return visit; reevaluate the survivor 3&ndash;7 days after initial assessment&nbsp;and assess tolerance of medications.
</p>
<p>
 &bull; If PEP is started, perform CBC and serum chemistry at baseline (initiation of PEP should not be delayed, pending&nbsp;results).
</p>
<p>
 &bull; Perform HIV antibody test at original assessment; repeat at 6 weeks, 3 months, and 6 months.
</p>
<p>
 Assistance with PEP-related decisions can be obtained by calling the National Clinician&rsquo;s Post-Exposure Prophylaxis Hotline (PEP Line) (telephone: 888-448-4911).
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

